StockWatch
·

Suven Pharmaceuticals Ltd Q2 FY26 Results

COHANCEQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue555.571.1%115.6%
Total Income571.171.4%110.1%
Expenditure487.401.1%182.8%
PBT83.7733.5%15.8%
Net Profit66.3943.1%19.0%
OPM21.77%2.85pp4.13pp
NPM11.62%3.39pp18.54pp
EPS1.9451.6%39.9%
View full financials

Informational and educational content only. Not investment advice.